For research use only. Not for therapeutic Use.
Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from patent WO2018114781A1, compound 43)[1].
| Catalog Number | I044004 |
| CAS Number | 2230880-25-6 |
| Synonyms | 4-[4-(4,5-dibromoimidazol-1-yl)-1,3-thiazol-2-yl]morpholine |
| Molecular Formula | C10H10Br2N4OS |
| Purity | ≥95% |
| InChI | InChI=1S/C10H10Br2N4OS/c11-8-9(12)16(6-13-8)7-5-18-10(14-7)15-1-3-17-4-2-15/h5-6H,1-4H2 |
| InChIKey | KEFGZKYLWGZFFS-UHFFFAOYSA-N |
| SMILES | C1COCCN1C2=NC(=CS2)N3C=NC(=C3Br)Br |
| Reference | [1]. Fuqiang Ban, et al. Ar-v7 inhibitors. Patent WO2018114781A1. |
